NCT00003462View on ClinicalTrials.gov

Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

busulfan

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER